BMY logo

Bristol-Myers Squibb Company (BMY) return on equity

annual ROE:

-39.01%-65.49%(-247.32%)
December 31, 2024

Summary

  • As of today (August 5, 2025), BMY annual return on equity is -39.01%, with the most recent change of -65.49% (-247.32%) on December 31, 2024.
  • During the last 3 years, BMY annual ROE has fallen by -57.94% (-306.08%).
  • BMY annual ROE is now -149.61% below its all-time high of 78.63%, reached on December 31, 2009.

Performance

1-year change

-247.32%

3-year change

-306.08%

5-year change

-473.3%

15-year change

-646.36%

BMY ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

48.49%
BMY annual return on equity is higher than 48.49% of companies in Healthcare sector

Range

All-time high

78.63%
BMY annual return on equity is currently -149.61% below its historical high of 78.63%

3-year low

-39.01%
BMY annual return on equity is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
BMY previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
BMY next annual earnings announcement has not yet been scheduled

OtherBMYprofitability metrics

Annual revenue

$48.30B
BMY annual revenue is $48.30 billion

annual net income

-$8.95B
BMY annual net profit is -$8.95 billion

Annual EPS

-$4.41
BMY annual earnings per share is -$4.41

Annual ROA

-9.53%
BMY annual return on assets is -9.53%

quarterly ROE:

29.49%-2.52%(-7.87%)
June 30, 2025

Summary

  • As of today (August 5, 2025), BMY quarterly return on equity is 29.49%, with the most recent change of -2.52% (-7.87%) on June 30, 2025.
  • Over the past year, BMY quarterly ROE has increased by +55.82% (+212.00%).
  • BMY quarterly ROE is now -61.97% below its all-time high of 77.54%, reached on December 31, 2009.

Performance

3-month change

-7.87%

1-year change

+212%

3-year change

+55.54%

5-year change

+2040.13%

BMY quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

86.82%
BMY quarterly return on equity is higher than 86.82% of companies in Healthcare sector

Range

All-time high

77.54%
BMY quarterly return on equity is currently -61.97% below its historical high of 77.54%

3-year low

-46.27%

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
BMY previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
BMY next earnings announcement is scheduled for Oct 30, 2025

OtherBMYprofitability metrics

Quarterly revenue

$12.27B
BMY quarterly revenue is $12.27 billion

quarterly net income

$1.31B
BMY quarterly net profit is $1.31 billion

Quarterly EPS

$0.64
BMY quarterly earnings per share is $0.64

Quarterly ROA

5.39%
BMY quarterly return on assets is 5.39%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

annual ROE

-39.01%
BMY annual return on equity is -39.01%

annual net income

-$8.95B
BMY annual net profit is -$8.95 billion

annual shareholders equity

$16.34B
BMY annual stockholders equity is $16.34 billion

BMY ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-247.3%+212.0%
3 y3 years-306.1%+55.5%
5 y5 years-473.3%+2040.1%

BMY ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-247.3%at low-7.9%+163.7%
5 y5-year-247.3%at low-7.9%+163.7%
alltimeall time-149.6%at low-62.0%+163.7%

BMY ROE History

DateAnnualQuarterly
Jun 2025
-
29.49%(-7.9%)
Mar 2025
-
32.01%(-169.2%)
Dec 2024
-39.01%(-247.3%)
-46.27%(+39.5%)
Sep 2024
-
-33.18%(+26.0%)
Jun 2024
-
-26.33%(+19.1%)
Mar 2024
-
-22.11%(-184.6%)
Dec 2023
26.48%(+40.5%)
26.13%(-1.1%)
Sep 2023
-
26.41%(+6.4%)
Jun 2023
-
24.82%(+8.7%)
Mar 2023
-
22.84%(+18.5%)
Dec 2022
18.85%(-0.4%)
19.27%(-1.7%)
Sep 2022
-
19.60%(+3.4%)
Jun 2022
-
18.96%(+8.9%)
Mar 2022
-
17.41%(-7.5%)
Dec 2021
18.93%(-194.0%)
18.83%(-239.3%)
Sep 2021
-
-13.52%(+12.8%)
Jun 2021
-
-11.99%(-13.2%)
Mar 2021
-
-13.82%(-26.7%)
Dec 2020
-20.13%(-292.6%)
-18.86%(>+9900.0%)
Sep 2020
-
-0.10%(-93.4%)
Jun 2020
-
-1.52%(-148.1%)
Mar 2020
-
3.16%(-78.9%)
Dec 2019
10.45%(-72.4%)
14.95%(-59.2%)
Sep 2019
-
36.67%(-15.2%)
Jun 2019
-
43.22%(+15.1%)
Mar 2019
-
37.54%(-0.7%)
Dec 2018
37.88%(+430.5%)
37.82%(+247.6%)
Sep 2018
-
10.88%(+287.2%)
Jun 2018
-
2.81%(-57.8%)
Mar 2018
-
6.66%(-4.2%)
Dec 2017
7.14%(-75.4%)
6.95%(-74.9%)
Sep 2017
-
27.68%(-7.6%)
Jun 2017
-
29.95%(-5.5%)
Mar 2017
-
31.69%(+8.3%)
Dec 2016
28.97%(+172.3%)
29.25%(+30.5%)
Sep 2016
-
22.41%(+16.5%)
Jun 2016
-
19.23%(+83.8%)
Mar 2016
-
10.46%(+1.2%)
Dec 2015
10.64%(-19.8%)
10.34%(-10.9%)
Sep 2015
-
11.61%(-0.7%)
Jun 2015
-
11.69%(-20.3%)
Mar 2015
-
14.67%(+11.7%)
Dec 2014
13.26%(-25.3%)
13.13%(-26.5%)
Sep 2014
-
17.86%(0.0%)
Jun 2014
-
17.86%(-9.1%)
Mar 2014
-
19.65%(+9.9%)
Dec 2013
17.75%(+33.6%)
17.88%(-9.0%)
Sep 2013
-
19.64%(+106.5%)
Jun 2013
-
9.51%(-5.0%)
Mar 2013
-
10.01%(-22.9%)
Dec 2012
13.29%(-43.6%)
12.99%(+7.7%)
Sep 2012
-
12.06%(-45.6%)
Jun 2012
-
22.15%(-6.6%)
Mar 2012
-
23.72%(+2.3%)
Dec 2011
23.55%(+15.5%)
23.19%(+10.6%)
Sep 2011
-
20.96%(-0.9%)
Jun 2011
-
21.15%(-2.4%)
Mar 2011
-
21.68%(+5.7%)
Dec 2010
20.39%(-74.1%)
20.52%(-70.6%)
Sep 2010
-
69.78%(-3.3%)
Jun 2010
-
72.13%(-3.8%)
Mar 2010
-
74.99%(-3.3%)
Dec 2009
78.63%(+70.6%)
77.54%(+169.5%)
Sep 2009
-
28.77%(-33.4%)
Jun 2009
-
43.21%(-1.4%)
Mar 2009
-
43.82%(-4.7%)
Dec 2008
46.09%(+118.7%)
45.99%(+31.6%)
Sep 2008
-
34.95%(+71.5%)
Jun 2008
-
20.38%(+1.7%)
Mar 2008
-
20.04%(-2.4%)
Dec 2007
21.07%(+40.9%)
20.53%(+4.1%)
Sep 2007
-
19.72%(+33.9%)
Jun 2007
-
14.73%(+4.0%)
Mar 2007
-
14.16%(+0.1%)
Dec 2006
14.95%
14.14%(-26.9%)
DateAnnualQuarterly
Sep 2006
-
19.34%(-23.1%)
Jun 2006
-
25.15%(-12.7%)
Mar 2006
-
28.81%(+3.4%)
Dec 2005
28.02%(+17.3%)
27.85%(+12.5%)
Sep 2005
-
24.76%(+6.8%)
Jun 2005
-
23.19%(+23.7%)
Mar 2005
-
18.74%(-19.0%)
Dec 2004
23.89%(-28.7%)
23.13%(-13.6%)
Sep 2004
-
26.76%(-7.0%)
Jun 2004
-
28.78%(-13.4%)
Mar 2004
-
33.25%(+1.7%)
Dec 2003
33.50%(+39.8%)
32.68%(+0.7%)
Sep 2003
-
32.44%(+23.7%)
Jun 2003
-
26.23%(+23.3%)
Mar 2003
-
21.28%(-3.4%)
Dec 2002
23.97%(-54.7%)
22.04%(-26.5%)
Sep 2002
-
29.97%(-21.3%)
Jun 2002
-
38.06%(-18.1%)
Mar 2002
-
46.46%(-12.5%)
Dec 2001
52.96%(+0.2%)
53.08%(+2.6%)
Sep 2001
-
51.71%(-3.1%)
Jun 2001
-
53.38%(+0.7%)
Mar 2001
-
53.03%(+0.6%)
Dec 2000
52.86%(+2.9%)
52.69%(+0.7%)
Sep 2000
-
52.31%(+0.5%)
Jun 2000
-
52.03%(+0.4%)
Mar 2000
-
51.82%(+0.7%)
Dec 1999
51.38%(+21.0%)
51.48%(+14.9%)
Sep 1999
-
44.80%(+0.7%)
Jun 1999
-
44.49%(+1.2%)
Mar 1999
-
43.97%(+3.0%)
Dec 1998
42.46%(-8.7%)
42.71%(-12.6%)
Sep 1998
-
48.86%(+1.2%)
Jun 1998
-
48.30%(+1.5%)
Mar 1998
-
47.58%(+1.8%)
Dec 1997
46.49%(+1.1%)
46.73%(+0.2%)
Sep 1997
-
46.66%(+0.7%)
Jun 1997
-
46.33%(+0.0%)
Mar 1997
-
46.31%(-0.1%)
Dec 1996
46.00%(+46.3%)
46.35%(+41.9%)
Sep 1996
-
32.67%(+2.9%)
Jun 1996
-
31.76%(+2.1%)
Mar 1996
-
31.10%(+3.0%)
Dec 1995
31.44%(-0.6%)
30.19%(-10.7%)
Sep 1995
-
33.80%(+2.2%)
Jun 1995
-
33.06%(+2.7%)
Mar 1995
-
32.19%(+4.1%)
Dec 1994
31.64%(-3.4%)
30.93%(-6.2%)
Sep 1994
-
32.98%(+0.8%)
Jun 1994
-
32.72%(+1.6%)
Mar 1994
-
32.20%(+0.4%)
Dec 1993
32.76%(-1.4%)
32.08%(-3.2%)
Sep 1993
-
33.15%(-0.1%)
Jun 1993
-
33.18%(+0.4%)
Mar 1993
-
33.04%(+0.2%)
Dec 1992
33.21%(-9.4%)
32.96%(-9.1%)
Sep 1992
-
36.27%(-1.3%)
Jun 1992
-
36.74%(-2.0%)
Mar 1992
-
37.49%(+1.1%)
Dec 1991
36.67%(+10.2%)
37.07%(+2.7%)
Sep 1991
-
36.10%(+1.9%)
Jun 1991
-
35.41%(+3.0%)
Mar 1991
-
34.37%(+3.6%)
Dec 1990
33.29%(+123.6%)
33.16%(+77.1%)
Sep 1990
-
18.72%(+7.0%)
Jun 1990
-
17.49%(+7.6%)
Mar 1990
-
16.25%(+7.2%)
Dec 1989
14.89%(-42.4%)
15.16%(-46.1%)
Sep 1989
-
28.15%(+4.2%)
Jun 1989
-
27.02%(+3.1%)
Mar 1989
-
26.21%(+3.4%)
Dec 1988
25.85%(+15.1%)
25.34%(-1.9%)
Sep 1988
-
25.83%(+7.8%)
Jun 1988
-
23.97%(+3.4%)
Mar 1988
-
23.18%(+3.2%)
Dec 1987
22.46%
22.46%

FAQ

  • What is Bristol-Myers Squibb Company annual return on equity?
  • What is the all time high annual ROE for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company annual ROE year-on-year change?
  • What is Bristol-Myers Squibb Company quarterly return on equity?
  • What is the all time high quarterly ROE for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company quarterly ROE year-on-year change?

What is Bristol-Myers Squibb Company annual return on equity?

The current annual ROE of BMY is -39.01%

What is the all time high annual ROE for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high annual return on equity is 78.63%

What is Bristol-Myers Squibb Company annual ROE year-on-year change?

Over the past year, BMY annual return on equity has changed by -65.49% (-247.32%)

What is Bristol-Myers Squibb Company quarterly return on equity?

The current quarterly ROE of BMY is 29.49%

What is the all time high quarterly ROE for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high quarterly return on equity is 77.54%

What is Bristol-Myers Squibb Company quarterly ROE year-on-year change?

Over the past year, BMY quarterly return on equity has changed by +55.82% (+212.00%)
On this page